- Home
- NVS vs PM Comparison
NVS vs PM Comparison
Compare NVS & PM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVS
- PM
- Stock Information
- Founded
- NVS 1895
- PM 1987
- Country
- NVS Switzerland
- PM United States
- Employees
- NVS N/A
- PM N/A
- Industry
- NVS Biotechnology: Pharmaceutical Preparations
- PM Medicinal Chemicals and Botanical Products
- Sector
- NVS Health Care
- PM Health Care
- Exchange
- NVS Nasdaq
- PM Nasdaq
- Market Cap
- NVS 230.5B
- PM N/A
- IPO Year
- NVS 1991
- PM N/A
- Fundamental
- Price
- NVS $112.56
- PM $155.15
- Analyst Decision
- NVS Hold
- PM Buy
- Analyst Count
- NVS 6
- PM 11
- Target Price
- NVS $123.67
- PM $138.55
- AVG Volume (30 Days)
- NVS 2.5M
- PM 6.0M
- Earning Date
- NVS 04-29-2025
- PM 04-23-2025
- Dividend Yield
- NVS 2.91%
- PM 3.48%
- EPS Growth
- NVS N/A
- PM N/A
- EPS
- NVS 5.87
- PM 4.52
- Revenue
- NVS $51,722,000,000.00
- PM $37,878,000,000.00
- Revenue This Year
- NVS $4.36
- PM $8.08
- Revenue Next Year
- NVS $1.93
- PM $8.00
- P/E Ratio
- NVS $19.18
- PM $34.33
- Revenue Growth
- NVS 10.85
- PM 7.69
- 52 Week Low
- NVS $92.35
- PM $87.82
- 52 Week High
- NVS $120.92
- PM $159.51
- Technical
- Relative Strength Index (RSI)
- NVS 57.67
- PM 61.16
- Support Level
- NVS $108.65
- PM $150.10
- Resistance Level
- NVS $112.24
- PM $152.98
- Average True Range (ATR)
- NVS 1.44
- PM 2.53
- MACD
- NVS -0.26
- PM -0.43
- Stochastic Oscillator
- NVS 80.52
- PM 74.31
About NVS Novartis AG
Novartis develops and manufactures innovative drugs. The firm's key areas of drug development include oncology, rare diseases, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.